Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Amortizatization of Intangibles (2018 - 2019)

Historic Amortizatization of Intangibles for BeOne Medicines (BEIGF) over the last 2 years, with Q3 2019 value amounting to -$51000.0.

  • BeOne Medicines' Amortizatization of Intangibles rose 9885.16% to -$51000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was -$7.3 million, marking a year-over-year decrease of 6428.73%. This contributed to the annual value of -$8.0 million for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q3 2019, BeOne Medicines' Amortizatization of Intangibles is -$51000.0, which was up 9885.16% from -$1.2 million recorded in Q2 2019.
  • Over the past 5 years, BeOne Medicines' Amortizatization of Intangibles peaked at -$51000.0 during Q3 2019, and registered a low of -$4.4 million during Q3 2018.